Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2019/132021
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a pharmaceutical composition capable of significantly inhibiting ABH8 gene expression. Provided is a pharmaceutical composition that includes: a liposome containing a cationic lipid; and an antisense nucleic acid against an ABH8 gene transcription product or a portion thereof.

Inventors:
TSUJIKAWA KAZUTAKE (JP)
NAITO TOMOHARU (JP)
HIGUCHI TAMAMI (JP)
SEKIGUCHI TAKAHIRO (JP)
ENDO TAISUKE (JP)
ISHIYAMA AYUMI (JP)
Application Number:
PCT/JP2018/048532
Publication Date:
July 04, 2019
Filing Date:
December 28, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV OSAKA (JP)
FUJIFILM CORP (JP)
International Classes:
A61K31/7088; A61K9/127; A61K47/10; A61K47/18; A61K47/28; A61K47/32; A61K48/00; A61P13/10; A61P35/00; C12N15/00
Foreign References:
JP2006111591A2006-04-27
JP2008178358A2008-08-07
JP2016023147A2016-02-08
Other References:
"Development of innovative drug for bladder cancer using ABH8-targeting synthetic nucleic acid", JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT, 23 May 2016 (2016-05-23), XP055624577, Retrieved from the Internet
KAWASAKI, RIKU ET AL.: "Protein transduction reagents", DRUG DELIVERY SYSTEM, vol. 31 - 2, 2016, pages 242 - 244, XP055624578
OHSHIO, IKUMI ET AL.: "ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 477, 2016, pages 413 - 418, XP029641753
SHIMADA, KEIJI ET AL.: "A Novel Human AlkB Homologue, ALKBH8 , Contributes to Human Bladder Cancer Progression", CANCER RESEARCH, vol. 69, 2009, pages 3157 - 3164, XP055624593
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF: